- The first case report of a patient with coexisting hemophilia B and Down syndrome
-
Rastogi P, Kumar N, Ahluwalia , Das R, Panigrahi
- KMID: 2375212
- Blood Res.
- 2017 Mar;52(1):75-76.
- doi: 10.5045/br.2017.52.1.75
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Inherited thrombophilia profile in patients with recurrent miscarriages: Experience from a tertiary care center in north India
-
Kumar N, Ahluwalia , Das R, Rohilla M, Bose S, Kishan H, Varma N
- KMID: 2314069
- Obstet Gynecol Sci.
- 2015 Nov;58(6):514-517.
- doi: 10.5468/ogs.2015.58.6.514
The cause of recurrent miscarriage (RM) remains unexplained in approximately 30% to 50% cases. The association of inherited thrombotic factors and RM patients has not been documented from the northern... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India: a retrospective cohort study
-
Kumar A, Kumar N, Pattanayak A, Kumar A, Palavesam S, Manigowdanahundi Nagaraju P, Das R
- KMID: 2557239
- Acute Crit Care.
- 2024 May;39(2):234-242.
- doi: 10.4266/acc.2023.00983
Background: Itolizumab downregulates the synthesis of proinflammatory cytokines and adhesion molecules by inhibiting CD6 leading to lower levels of interferon-γ, interleukin-6, and tumor necrotic factor-α and reduced T-cell infiltration at... -
- CITED
-
- Close
- SHARE
-
- Close
- Modulation of the LIMK Pathway by Myricetin: A Protective Strategy Against Neurological Impairments in Spinal Cord Injury
-
Roy A, Sen S, Das R, Shard A, Kumar H
- KMID: 2560322
- Neurospine.
- 2024 Sep;21(3):878-889.
- doi: 10.14245/ns.2448546.273
Objective: Spinal cord injury (SCI), one of the major disabilities concerning central nervous system injury, results in permanent tissue loss and neurological impairment. The existing therapeutic options for SCI are... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature
-
Bommannan , Sachdeva M, Malhotra P, Kumar N, Sharma P, Naseem S, Ahluwalia , Das R, Varma N, Prakash G, Khadwal A, Srinivasan R, Varma S
- KMID: 2172741
- Blood Res.
- 2016 Mar;51(1):23-30.
- doi: 10.5045/br.2016.51.1.23
BACKGROUND: Plasma cell leukemia (PCL) is a rare and aggressive plasma cell neoplasm. In PCL, clonal plasma cells comprise ≥20% of the peripheral blood (PB) leukocytes and/or the absolute clonal... -
- CITED
-
- Close
- SHARE
-
- Close
